The rise of Viagra initially sparked a period of growth for major pharmaceutical companies, nevertheless recent shifts present a murky scenario for shareholders. Off-patent competitors are eroding profits, and https://lewyswnhq775529.blogdemls.com/40969978/the-blue-pill-and-the-pharmaceutical-industry-a-precarious-bet